Cannabis Bioscience International Holdings Past Earnings Performance
Past criteria checks 0/6
Cannabis Bioscience International Holdings has been growing earnings at an average annual rate of 8%, while the Life Sciences industry saw earnings declining at 3.7% annually. Revenues have been declining at an average rate of 18.4% per year.
Key information
8.01%
Earnings growth rate
15.64%
EPS growth rate
Life Sciences Industry Growth
21.51%
Revenue growth rate
-18.42%
Return on equity
n/a
Net Margin
-416.81%
Last Earnings Update
28 Feb 2026
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Cannabis Bioscience International Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:CBIH Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
28 Feb 26
0
-1
0
0
30 Nov 25
0
-1
1
0
31 Aug 25
0
-1
1
0
31 May 25
0
-1
1
0
28 Feb 25
0
0
1
0
30 Nov 24
0
-1
1
0
31 Aug 24
0
-1
1
0
31 May 24
0
-1
1
0
29 Feb 24
0
-1
1
0
30 Nov 23
0
-1
1
0
31 Aug 23
0
-1
1
0
31 May 23
0
-1
1
0
28 Feb 23
0
-1
1
0
30 Nov 22
0
-1
1
0
31 Aug 22
0
-1
1
0
31 May 22
0
-1
1
0
28 Feb 22
0
-1
1
0
31 May 21
1
0
1
0
31 May 20
0
-1
1
0
Quality Earnings: CBIH is currently unprofitable.
Growing Profit Margin: CBIH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CBIH is unprofitable, but has reduced losses over the past 5 years at a rate of 8% per year.
Accelerating Growth: Unable to compare CBIH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CBIH is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (12.6%).
Return on Equity
High ROE: CBIH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/27 17:51
End of Day Share Price
2026/07/24 00:00
Earnings
2026/02/28
Annual Earnings
2025/05/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cannabis Bioscience International Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.